AstraZeneca PLC’s new CEO has stamped his authority on Britain’s second-biggest medicine maker by jettisoning its chiefs of research and commercial operations and revamping the pure pharma’s top team.
Pascal Soriot, a former executive at Rochewho took the over the reins at AstraZeneca in October 2012 said Jan
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?